The Ozempic ‘miracle’: Bangladesh’s growing appetite for quick weight-loss fixes | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
July 10, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, JULY 10, 2025
The Ozempic ‘miracle’: Bangladesh’s growing appetite for quick weight-loss fixes

Panorama

Imran Hossain
24 May, 2025, 08:35 pm
Last modified: 24 May, 2025, 09:34 pm

Related News

  • Enteric Fever: Causes and treatment of this common disease in Bangladesh
  • 6 things you should know to lose weight in winter
  • Novo's trial of weight-loss drug shows improvement in fatty liver disease
  • Lizzo’s witty Halloween ozempic nod to South Park
  • How fake Ozempic batch numbers help criminal groups spread dangerous drugs

The Ozempic ‘miracle’: Bangladesh’s growing appetite for quick weight-loss fixes

Locally produced versions of drugs like Semaglutide are helpful for patients with obesity and diabetes, but unprescribed use raises concerns

Imran Hossain
24 May, 2025, 08:35 pm
Last modified: 24 May, 2025, 09:34 pm
Illustration: TBS
Illustration: TBS

Mohsin recalls the days when he was significantly overweight, with a Body Mass Index (BMI) over 33, and a big appetite that contributed to his condition. 

"At the time, not only was I dealing with diabetes, but I was also considerably overweight," he said.

Two years ago, he began taking medication to address the issue, and since then, his health has undergone a profound transformation — he reports having lost more than 25 kilograms and no longer needing insulin.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

"I am not diabetic anymore," he said. 

Mohsin's story is one of many now emerging across Bangladesh, where the rising popularity of weight loss drugs is changing the way patients and doctors alike approach obesity and associated illnesses.

While exercise and calorie control remain central to medical recommendations, new pharmacological tools are offering a vital — and sometimes controversial — lifeline.

Obesity is no longer a distant Western concern. It is a growing problem in Bangladesh, with increasingly sedentary lifestyles and changing food habits.

Dr Jobaida Nazneen, assistant professor of Endocrinology and Metabolism at Shaheed Suhrawardy Medical College and Hospital, emphasised the seriousness of the issue.

"Obesity is a chronic, often relapsing disease with numerous metabolic, physical and psychosocial complications," she explained. "Obese individuals are 80 times more likely to develop type 2 diabetes, and at a two to three times increased risk of heart disease, hypertension and stroke."

According to Dr Nazneen, losing just 5-7% of one's body weight can already lead to significant health benefits. "It can delay diabetes progression and improve cardiovascular outcomes," she said.

However, she added that these outcomes require a combination of calorie reduction, exercise and sometimes pharmacological assistance.

Understanding the medications

In Bangladesh, several types of weight loss drugs are available, though none are from the original manufacturers. Local pharmaceutical companies produce biosimilar versions of the drugs, which are more affordable and widely accessible.

Among the most discussed drugs are Orlistat, Semaglutide (widely known by its original brand Ozempic), and Liraglutide (Victoza).

Orlistat prevents dietary fat absorption by blocking lipase, an enzyme in the gut. "Common side effects include oily spotting on underwear, flatulence with discharge, fatty stool, increased defecation, nausea, and vomiting," Dr Nazneen said. Orlistat is the least effective among the available options, but also the oldest.

Semaglutide and Liraglutide reduce appetite and slow gastric emptying, leading to a prolonged sense of fullness. A newer dual agonist, Tirzepatide, works even more powerfully by combining glucagon-like polypeptide (GLP-1) and gastric inhibitory polypeptide (GIP) agonist effects.

"These medicines often lead to gastrointestinal issues," Dr Nazneen explained, listing vomiting, constipation, abdominal pain and indigestion.

"But the more serious side effects such as kidney damage, gallbladder disease and stomach paralysis are rare — around 1-2% percent in studies."

The benefits, though, can be significant. As Mohsin's case shows, not only can weight be reduced, but illnesses like diabetes can also be managed or even reversed.

A worrying trend

While these drugs have opened doors to better health for many, their unregulated distribution is a cause for concern.

"These precious drugs are being sold by the pharmacy sales people without a prescription of a registered physician," Dr Nazneen warned.

"Some so-called beauty clinics are offering these medications as a 'magic cure.' Without the monitoring of the health ministry, this situation will worsen."

The marketing of these drugs as quick solutions has also raised ethical questions.

"Certainly, we could say that these drugs promote a quick fix mentality," Dr Nazneen said. "But we have to consider the weight stigma that people with obesity face since childhood. Fat bias is prevalent among healthcare professionals and the general public."

She argued for a more compassionate approach, suggesting, "Increasing empathy and understanding about the complexity of weight management has to be emphasised."

A tool, not a cure

Experts stress that medications are just one piece of the puzzle. Lifestyle modifications, including diet and physical activity, remain essential.

"Anti-obesity medications are a tool of treatment, not a cure," said Dr Nazneen. "Discontinuing these drugs without following lifestyle modifications often leads to rapid weight regain."

She advised that patients set realistic expectations — ideally, a 5-10% weight loss within six months.

Ongoing monitoring is also critical. "It is advised to assess their effectiveness and safety at least monthly for the first three months and quarterly thereafter," she added.

In long-term users, follow-ups should be arranged to check for pancreatitis, gastroparesis, gallbladder disease, and kidney injury.

"Each patient has to be counselled about gastrointestinal side effects and some common medications are given to lower the side effects. A routine follow-up at least within a month is advised," said the doctor.

Local market and concerns

Bangladesh's reliance on biosimilar drugs has both advantages and limitations.

The affordability makes the medications accessible to more people; for example, a local 1.34 mg vial of Semaglutide costs around Tk5,000, compared to the originator brand, which is priced at over Tk14,000.

While originator brands are scarce worldwide, Bangladesh is not facing a shortage, thanks to local manufacturing. 

But questions remain about long-term safety and efficacy.

"We are receiving biosimilar products manufactured by our Bangladeshi pharmaceutical companies," said Dr Nazneen.

"It is mandatory to pass a bioequivalence test for all biosimilar products. These are usually conducted at BCSIR [Bangladesh Council of Scientific and Industrial Research] or in India due to the lack of advanced labs locally."

Backed by science

Though these drugs are not miracle solutions, the science behind them is growing stronger.

A recent study from Washington University has found that weight-loss drugs like Ozempic and Wegovy may offer wide-ranging health benefits, including better heart health, reduced risk of dementia, fewer infections, and improved mental wellbeing.

The drugs, originally used for type 2 diabetes, mimic a gut hormone that influences appetite and also affects various organs. Researchers found a 12% drop in Alzheimer's cases and lower rates of substance abuse and chronic conditions among users.

However, the study also revealed increased risks of digestive issues, joint pain and inflammation in the pancreas. 

While the findings are promising, experts urge caution, noting the study's limited diversity and the need for further trials.

The full impact of these drugs is still being understood, and their broader use requires careful consideration.

Yet patients are satisfied with the outcomes.

Mohsin is currently on Tirzepatide, having previously been treated with Semaglutide.

"My life has been smooth sailing, without any notable side effects — I never felt better," he said. "As long as the diabetes remains under control, the weight will not go up again. It is important to keep diabetes in check."

Yet even the most advanced drug cannot replace the human side of care. Dr Nazneen emphasised a non-judgmental approach.

"We have to advocate that obesity management extends beyond physical appearance, targeting profound metabolic and cardiovascular risks. A non-judgmental interaction with a person with obesity will ensure that he or she understands the supreme importance of diet and exercise," she concluded.

 

Top News

weight loss / ozempic

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Representational image. Photo: Syed Zakir Hossain/TBS
    Explainer: Why SSC pass rate hit a 17-year low
  • Council of Advisers' meeting on Thursday (10 July). Photo: CA Press Wing
    Govt cancels 'Sir' address directive from Hasina's rule
  • Sri Lanka cruise to seven-wicket win over Bangladesh in first T20I
    Sri Lanka cruise to seven-wicket win over Bangladesh in first T20I

MOST VIEWED

  • Graphics: TBS
    BB raises startup fund limit, drops upper age barrier
  • Workers pack undergarments at the packing section of a garment factory in Ashulia, on the outskirts of Dhaka, Bangladesh, April 19, 2025. Photo: REUTERS/Fatima Tuj Johora
    After US tariffs, jobs hang by a thread in Bangladesh's garments sector
  • Photo: Mohammad Minhaj Uddin/TBS
    SSC, equivalent results: Pass rate drops to 68.45%, GPA-5 also declines
  • File photo of containers at Chattogram port/TBS
    US buyers push Bangladeshi exporters to share extra tariff costs
  • Govt vehicle purchase, foreign trip, new building construction banned: Finance ministry
    Govt vehicle purchase, foreign trip, new building construction banned: Finance ministry
  • Students sit for SSC exam at Motijheel Girls' High School on 10 April 2025. Photo: Mehedi Hasan/TBS
    SSC exam results out: Here's how you can check online and via SMS

Related News

  • Enteric Fever: Causes and treatment of this common disease in Bangladesh
  • 6 things you should know to lose weight in winter
  • Novo's trial of weight-loss drug shows improvement in fatty liver disease
  • Lizzo’s witty Halloween ozempic nod to South Park
  • How fake Ozempic batch numbers help criminal groups spread dangerous drugs

Features

Photo: Collected/BBC

What Hitler’s tariff policy misfire can teach the modern world

2h | The Big Picture
Illustration: TBS

Behind closed doors: Why women in Bangladesh stay in abusive marriages

5h | Panorama
Purbachl’s 144-acre Sal forest is an essential part of the area’s biodiversity. Within it, 128 species of plants and 74 species of animals — many of them endangered- have been identified. Photo: Syed Zakir Hossain/TBS

A forest saved: Inside the restoration of Purbachal's last Sal grove

5h | Panorama
Women are forced to fish in saline waters every day, risking their health to provide for their families. Photo: TBS

How Mongla’s women are bearing the brunt of rising salinity

1d | Panorama

More Videos from TBS

'Hypocrisy' will not continue, Iran tells IAEA

'Hypocrisy' will not continue, Iran tells IAEA

1h | TBS World
OpenAI to release web browser in challenge to Google Chrome

OpenAI to release web browser in challenge to Google Chrome

52m | TBS World
Will the title 'Honorable and Excellency' be abolished?

Will the title 'Honorable and Excellency' be abolished?

1h | TBS Today
July Declaration must be constitutionally recognized: Akhtar Hossain

July Declaration must be constitutionally recognized: Akhtar Hossain

1h | TBS Today
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net